KONINKLIJKE DSM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114 EUR | +0.13% |
|
-.--% | -.--% |
| 09:54am | Dsm-firmenich to De-prioritize Certain Business Activities Under New Strategy | MT |
| 07:40am | DSM-Firmenich sees mid-term adjusted EBITDA margin of 22-23% | RE |
| Sales 2024 * | 12.62B 13.67B | Sales 2025 * | 13.27B 14.37B | Capitalization | 28.03B 30.36B |
|---|---|---|---|---|---|
| Net income 2024 * | 453M 491M | Net income 2025 * | 810M 878M | EV / Sales 2024 * | 2.46 x |
| Net Debt 2024 * | 2.95B 3.2B | Net Debt 2025 * | 2.69B 2.91B | EV / Sales 2025 * | 2.32 x |
| P/E ratio 2024 * |
60.7
x | P/E ratio 2025 * |
34.8
x | Employees | 28,685 |
| Yield 2024 * |
2.38% | Yield 2025 * |
2.34% | Free-Float | 25.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Koninklijke DSM
More press releases
More news
| 1 day | +0.13% |
3 years
105.80
200.50
5 years
82.20200.50
10 years
38.71200.50
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
| Director/Board Member | 62 | 23-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.43% | 304 M€ | +16.75% | ||
| 1.13% | 17 M€ | +7.32% | - |
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
2024-06-02
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
105.6
EUR
Average target price
121.9
EUR
Spread / Average Target
+15.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.62% | 896B | |
| +2.20% | 243B | |
| +29.39% | 181B | |
| +62.88% | 95.16B | |
| -7.33% | 72.44B | |
| -8.40% | 55.41B | |
| +37.82% | 35.68B | |
| -39.04% | 29.56B | |
| +68.67% | 29.24B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock
